J&J units launch prostate cancer drug suit

31-05-2022

Sarah Speight

J&J units launch prostate cancer drug suit

Michael Vi / Shutterstock.com

Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada (apalutamide).


Aragon, Janssen, University of California, Sloan-Kettering, cancer drugs, patents, Eugia, Aurobindo, AuroMedics, Johnson & Johnson

LSIPR